Discovery of a Rapidly Metabolized, Long-Acting β2Adrenergic Receptor Agonist with a Short Onset Time Incorporating a Sulfone Group Suitable for Once-Daily Dosing
Year: 2013
Type: article
Source: Journal of Medicinal Chemistry
DOI: 10.1021/jm401532g
Institution: GlaxoSmithKline (United Kingdom)
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: closed
Funder: GlaxoSmithKline
OpenAlex ID: W2314874151
